Literature DB >> 9460163

Cervical amyloidoma of C2. Case report and review of the literature.

F Porchet1, V K Sonntag, N Vrodos.   

Abstract

STUDY
DESIGN: Second published report of a patient with amyloidoma of the upper cervical spine.
OBJECTIVES: To describe a patient with rare radiculopathy to alert other physicians to consider amyloid tumor as a differential diagnosis of locally destructive spine lesions. SUMMARY OF BACKGROUND DATA: Localized amyloid tumor of the bone is a rare disease. Only seven cases of spine involvement have been reported. Appropriate tissue sampling is required to establish the diagnosis. Histopathologic examination shows pathognomonic apple-green birefringence under polarized light. When bone is involved with amyloid, it is most commonly associated with multiple myeloma or other plasma cell-dyscrasias.
METHOD: This case was described, and pertinent literature was reviewed.
RESULTS: The patient showed persistent neurologic improvement after transoral complete tumor removal, followed by a secondary posterior stabilization procedure using transarticular C1-C2 screws.
CONCLUSIONS: Amyloidomas are benign lesions with no associated documented risk for the development of plasmocytoma-related diseases. The clinical and radiographic manifestations of this lesion are nonspecific. A cure is possible with complete resection of the tumor and no adjuvant management procedures.

Entities:  

Mesh:

Year:  1998        PMID: 9460163     DOI: 10.1097/00007632-199801010-00027

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  Amyloidoma of the skull base.

Authors:  W A Simoens; L van den Hauwe; E Van Hedent; F Warson; R Demaeseneer; D Williams; A M De Schepper
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  MRI of pathology-proven peripheral nerve amyloidosis.

Authors:  Gavin A McKenzie; Stephen M Broski; Benjamin M Howe; Robert J Spinner; Kimberly K Amrami; Angela Dispenzieri; Michael D Ringler
Journal:  Skeletal Radiol       Date:  2016-10-12       Impact factor: 2.199

3.  Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma.

Authors:  Adam J Loavenbruck; Vinay Chaudhry; Steven R Zeldenrust; Robert J Spinner; Jason D Theis; Christopher J Klein
Journal:  Muscle Nerve       Date:  2012-11       Impact factor: 3.217

4.  The anatomic study of clival screw fixation for the craniovertebral region.

Authors:  Wei Ji; Xiang-Yang Wang; Hua-Zi Xu; Xin-Dong Yang; Yong-Long Chi; Jian-Sheng Yang; Sun-Fang Yan; Jian-Wu Zheng; Zhong-Xiao Chen
Journal:  Eur Spine J       Date:  2012-08       Impact factor: 3.134

5.  Primary amyloidosis presenting as upper limb multiple mononeuropathies.

Authors:  Jennifer A Tracy; Peter J Dyck; P James B Dyck
Journal:  Muscle Nerve       Date:  2010-05       Impact factor: 3.217

6.  Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

Authors:  Adam J Loavenbruck; Wolfgang Singer; Michelle L Mauermann; Paola Sandroni; P James B Dyck; Morie Gertz; Christopher J Klein; Phillip A Low
Journal:  Ann Neurol       Date:  2016-07-25       Impact factor: 10.422

Review 7.  Primary amyloidoma of the axis and acute spinal cord compression: a case report.

Authors:  Denis Mulleman; René-Marc Flipo; Richard Assaker; Claude-Alain Maurage; Patrick Chastanet; Vincent Ducoulombier; Xavier Deprez; Bernard Duquesnoy
Journal:  Eur Spine J       Date:  2004-03-16       Impact factor: 3.134

Review 8.  Cervical amyloidoma of transthyretin type: a case report and review of literature.

Authors:  Matthew H MacLennan; André le Roux
Journal:  BMC Geriatr       Date:  2022-09-15       Impact factor: 4.070

9.  Primary solitary retro-clival amyloidoma.

Authors:  Julia R Schneider; Kevin Kwan; Kay O Kulason; Lukas J Faltings; Stephanie Colantonio; Scott Safir; Tina Loven; Jian Yi Li; Karen S Black; B Todd Schaeffer; Mark B Eisenberg
Journal:  Surg Neurol Int       Date:  2018-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.